BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2289837)

  • 1. Model of removal of immunoglobulins from plasma by extracorporeal immunoadsorption with sepharose-protein A.
    Davies PA
    Int J Artif Organs; 1990 Dec; 13(12):837-45. PubMed ID: 2289837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption of human plasma with protein A-sepharose columns.
    Branda RF; Miller WJ; Soltis RD; McCullough JJ
    Transfusion; 1986; 26(5):471-7. PubMed ID: 3532448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose.
    Braun N; Gutenberger S; Erley CM; Risler T
    Transfus Sci; 1998 Mar; 19 Suppl():25-31. PubMed ID: 10178689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
    Fennelly DW; Norton L; Sznol M; Hakes TB
    Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoabsorption in an extracorporeal plasma perfusion system: in vitro studies.
    Burgstaler EA; Pineda AA
    Artif Organs; 1981 Aug; 5(3):259-63. PubMed ID: 7030281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical and clinical experience with protein A immunoadsorption columns.
    Belàk M; Borberg H; Jimenez C; Oette K
    Transfus Sci; 1994 Dec; 15(4):419-22. PubMed ID: 10155559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unexpected complication following immunoadsorption with a staphylococcal protein A column.
    Huestis DW; Rifkin RM; Durie BG; Sibley WA; Irani M
    J Clin Apher; 1992; 7(2):75-7. PubMed ID: 1429491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoadsorption of anti-HLA antibodies on protein A-sepharose columns in hyperimmunized recipients waiting for transplantation].
    Kriaa F; Hiesse C; Farahmand H; Bismuth A; Charpentier B
    Ann Med Interne (Paris); 1994; 145(5):324-7. PubMed ID: 7985941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients.
    Wallmark A; Grubb A; Freiburghaus C; Flodgren P; Husberg B; Lindholm T; Lindström C; Thysell H; Sjögren HO
    Artif Organs; 1984 Feb; 8(1):72-81. PubMed ID: 6367720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases.
    Fabrizio F; Luzzatto G; Ramon R; Randi ML; De Silvestro G; Girolami A
    Haematologica; 2000 Aug; 85(8):888-90. PubMed ID: 10942951
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoadsorption for coagulation factor inhibitors.
    Uehlinger J; Button GR; McCarthy J; Forster A; Watt R; Aledort LM
    Transfusion; 1991; 31(3):265-9. PubMed ID: 2003328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HLA antibodies depletion on protein A-sepharose columns in hyperimmunized patients awaiting renal transplantation.
    Kriaa F; Rousseau P; Hiesse C; Farahmand H; Brocard JF; Rieu P; Lantz O; Farquet C; Bismuth A; Benoit G
    Ann Med Interne (Paris); 1992; 143 Suppl 1():39-42. PubMed ID: 1300886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
    Pták J
    Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein A tangential flow affinity membrane cartridge for extracorporeal immunoadsorption therapy.
    Jia L; Yang L; Zou H; Zhang Y; Zhao J; Fan C; Sha L
    Biomed Chromatogr; 1999 Nov; 13(7):472-7. PubMed ID: 10534759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protein A tangential flow membrane chromatographic column used for immunoadsorption therapy].
    Jia L; Yang L; Zou H; Zhang Y; Zhao J; Fan C; Sha L
    Se Pu; 1999 Mar; 17(2):107-11. PubMed ID: 12549145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific removal of antibodies with an immunoadsorption system.
    Branda RF; Klausner JS; Miller WJ; Soltis RD
    Transfusion; 1984; 24(2):157-63. PubMed ID: 6369656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background and indications for protein A-based extracorporeal immunoadsorption.
    Matic G; Bosch T; Ramlow W
    Ther Apher; 2001 Oct; 5(5):394-403. PubMed ID: 11778926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific removal of transthyretin from plasma of patients with familial amyloidotic polyneuropathy: optimization of an immunoadsorption procedure.
    Regnault V; Costa PM; Teixeira A; Rivat C; Stoltz JF; Saraiva MJ; Costa PP
    Int J Artif Organs; 1992 Apr; 15(4):249-55. PubMed ID: 1316882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.
    Koll RA
    Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
    Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
    Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.